Chandigarh, May 13: Park MediWorld Limited, North India’s second-largest hospital chain (NSE: PARKHOSPS, BSE: 544645), today announced its audited financial results for the quarter and financial year ended March 31, 2026, reporting its strongest-ever annual performance across revenue, profitability, operational expansion, and balance sheet strength.
FY26 Financial Highlights
The company recorded its highest-ever annual revenue of INR 16,794 million, registering a growth of 21% year-on-year. EBITDA for the year stood at a record INR 4,443 million, up 20% YoY, with EBITDA margins maintained at a healthy 26.5%.
Net Profit for FY26 reached an all-time high of INR 2,736 million, reflecting a 27% YoY growth, while Net Profit margins improved to 16.3%, expanding by 83 basis points compared to the previous year.
The company also generated cash from operations of INR 3,291 million during the year and significantly reduced debtor days from 161 days as of March 31, 2025, to 129 days as of March 31, 2026.
Park MediWorld further strengthened its financial position with negligible term bank debt of INR 282 million and maintained strong liquidity with INR 3,141 million in fixed deposits and total cash and cash equivalents of INR 5,509 million.
Expansion and Growth Initiatives
FY26 marked the company’s largest-ever capacity expansion year, with 610 beds added through acquisitions in Bathinda and Agra, taking total bed capacity to 3,610 beds as of March 31, 2026.
The company also completed construction and commissioning of its largest greenfield hospital in Panchkula with 350 beds, operational from April 10, 2026, increasing total operational bed capacity to 3,960 beds.
Additionally, Park MediWorld completed the acquisition of Febris Multi-Superspeciality Hospital in Narela, Delhi, with a capacity of 200 beds, expected to become operational in Q2 FY27.
The company also secured approvals for a 150-bed expansion at its Mohali facility, which will increase the hospital’s total capacity to 500 beds. Upon completion, the company is expected to become the largest private healthcare provider in the Tricity region with a combined capacity of 850 beds.
Q4 FY26 Performance Highlights
For the quarter ended March 31, 2026, the company reported its highest-ever quarterly revenue of INR 4,604 million, reflecting a 30% YoY growth.
Quarterly EBITDA rose 44% YoY to INR 1,274 million, with EBITDA margins improving to 27.7%, an expansion of 268 basis points.
Net Profit for the quarter increased 47% YoY to INR 768 million, while Net Profit margins improved to 16.7%.
Management Commentary
Commenting on the company’s performance, Dr. Ajit Gupta and Dr. Ankit Gupta said:
“FY26 was the finest year in Park MediWorld’s history — a year in which we delivered record financial and operating performance, executed our largest-ever capacity addition, and strengthened our balance sheet, all simultaneously. That combination of growth, profitability, and financial discipline moving in the same direction at the same time is the clearest possible validation of the model we have built over two decades.”
They further added:
“Post our IPO, we remain firmly focused on disciplined capital allocation, balance sheet strength, and measured expansion. Our immediate priorities are the seamless integration of acquired assets, improving utilisation across newer facilities, and sustaining the profitability that we have delivered. Over the medium term, we will continue to selectively pursue growth opportunities while maintaining our unwavering commitment to delivering affordable, high-quality healthcare and creating long-term value for all our stakeholders.”